Intranasal lipopeptide primes lung-resident memory CD8+ T cells for long-term pulmonary protection against influenza

European Journal of Immunology

Volumn 36, Issue 3, 2006, Pages 770-778

  Deliyannis, Georgia ^a,b   Kedzierska, Katherine ^a   Lau, Yuk Fai ^a   Zeng, Weiguang ^a   Turner, Stephen J ^a   Jackson, David C ^a,b   Brown, Lorena E ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b VacTX Pty Ltd   (Australia)

Author keywords

Influenza; Lipopeptide; Lung; T cells; Vaccination

Indexed keywords

[2,3 BIS(PALMITOYLOXY)PROPYL]CYSTEINE; GAMMA INTERFERON; INFLUENZA VACCINE; LIPOPEPTIDE; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANTIVIRAL ACTIVITY; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR DISTRIBUTION; CELLULAR IMMUNITY; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG EFFICACY; DRUG POTENCY; DRUG SYNTHESIS; EXPOSURE; FEMALE; INFLUENZA A; INTERFERON PRODUCTION; LUNG; LYMPHOCYTE COUNT; LYMPHOCYTE SUBPOPULATION; MEDIASTINUM LYMPH NODE; MEMORY CELL; MEMORY T LYMPHOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; VACCINATION; VIRUS TITRATION;

ADMINISTRATION, INTRANASAL; ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; EPITOPES, T-LYMPHOCYTE; FEMALE; HUMANS; IMMUNOLOGIC MEMORY; INFLUENZA A VIRUS; INFLUENZA VACCINES; INFLUENZA, HUMAN; INTERFERON TYPE II; LIPOPROTEINS; LUNG; LYMPH NODES; MICE; MICE, INBRED BALB C; VACCINES, SYNTHETIC;

EID: 33644952046     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200535217     Document Type: Article

References (28)

1. Liang, S., Mozdzanowska, K., Palladino, G. and Gerhard, W., Hetero-subtypic immunity to influenza type A virus in mice. Effector mechanisms and their longevity. J. Immunol. 1994. 152: 1653-1661.
2. + T cells persist in the lungs following recovery from respiratory virus infections. J. Immunol. 2001. 166: 1813-1822.
3. Ostler, T., Hussell, T., Surh, C. D., Openshaw, P. and Ehl, S., Long-term persistence and reactivation of T cell memory in the lung of mice infected with respiratory syncytial virus. Eur. J. Immunol. 2001. 31: 2574-2582.
4. + T cells in the lung airways retain the potential to mediate recall responses. J. Immunol. 2003. 171: 3338-3342.
5. BenMohamed, L., Wechsler, S. L. and Nesburn, A. B., Lipopeptide vaccines-yesterday, today, and tomorrow. Lancet Infect. Dis. 2002. 2: 425-431.
6. Brown, L. E. and Jackson, D. C., Lipid-based self-adjuvanting vaccines. Curr. Drug Deliv. 2005. 2: 383-393.
7. Muhlradt, P. F., Kiess, M., Meyer, H., Sussmuth, R and Jung, G., Isolation, structure elucidation, and synthesis of a macrophage stimulatory lipopeptide from Mycoplasma fermentans acting at picomolar concentration. J. Exp. Med. 1997. 185: 1951-1958.
8. Jackson, D. C., Lau, Y. F., Le, T., Suhrbier, A., Deliyannis, G., Cheers, C., Smith, C. et al., A totally synthetic vaccine of generic structure that targets Toll-like receptor 2 on dendritic cells and promotes antibody or cytotoxic T cell responses. Proc. Natl. Acad. Sci. USA 2004. 101: 15440-15445.
9. Deliyannis, G., Jackson, D. C., Ede, N. J., Zeng, W., Hourdakis, I., Sakabetis, E. and Brown, L. E., Induction of long-term memory CD8(+) T cells for recall of viral clearing responses against influenza virus. J. Virol. 2002. 76: 4212-4221.
10. Jung, T. M., Gallatin, W. M., Weissman, I. L. and Dailey, M. O., Down-regulation of homing receptors after T cell activation. J. Immunol. 1988. 141: 4110-4117.
11. Pereira, M. S., Problems in the control of epidemic influenza by vaccination. Ann. Clin. Res. 1982. 14: 220-224.
12. Baumgarth, N. and Kelso, A., Functionally distinct T cells in three compartments of the respiratory tract after influenza virus infection. Eur. J. Immunol. 1996. 26: 2189-2197.
13. + T cells. Proc. Natl. Acad. Sci. USA 2001. 98: 6313-6318.
14. Sallusto, F., Lenig, D., Forster, R., Lipp, M. and Lanzavecchia, A., Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 1999. 401: 708-712.
15. Christensen, J. P., Doherty, P. C., Branum, K. C. and Riberdy, J. M., Profound protection against respiratory challenge with a lethal H7N7 influenza A virus by increasing the magnitude of CD8(+) T-cell memory. J. Virol. 2000. 74: 11690-11696.
16. Nguyen, H. H., Moldoveanu, Z., Novak, M. J., van Ginkel, F. W., Ban, E., Kiyono, H., McGhee, J. R. et al., Heterosubtypic immunity to lethal influenza A virus infection is associated with virus-specific CD8(+) cytotoxic T lymphocyte responses induced in mucosa-associated tissues. Virology 1999. 254: 50-60.
17. Riberdy, J. M., Christensen, J. P., Branum, K. and Doherty, P. C., Diminished primary and secondary influenza virus-specific CD8(+) T-cell responses in CD4-depleted Ig(-/-) mice. J. Virol. 2000. 74: 9762-9765.
18. Belz, G. T., Wodarz, D., Diaz, G., Nowak, M. A. and Doherty, P. C., Compromised influenza virus-specific CD8(+)-T-cell memory in CD4(+)-T-cell-deficient mice. J. Virol. 2002. 76: 12388-12393.
19. + T lymphocytes. Nature 2003. 421: 852-856.
20. Shedlock, D. J. and Shen, H., Requirement for CD4 T cell help in generating functional CD8 T cell memory. Science 2003. 300: 337-339.
21. Sun, J. C. and Bevan, M. J., Defective CD8 T cell memory following acute infection without CD4 T cell help. Science 2003. 300: 339-342.
22. Zeng, W., Ghosh, S., Lau, Y. F., Brown, L. E. and Jackson, D. C., Highly immunogenic and totally synthetic lipopeptides as self-adjuvanting immunocontraceptive vaccines. J. Immunol. 2002. 169: 4905-4912.
23. + T cells within the light chain of the H3 hemagglutinin molecule of influenza virus. Virology 1994. 198: 613-623.
24. Bodmer, H. C., Pemberton, R. M., Rothbard, J. B. and Askonas, B. A., Enhanced recognition of a modified peptide antigen by cytotoxic T cells specific for influenza nucleoprotein. Cell 1988. 52: 253-258.
25. Sherman, L. A., Burke, T. A. and Biggs, J. A., Extracellular processing of peptide antigens that bind class I major histocompatibility molecules. J. Exp. Med. 1992. 175: 1221-1226.
26. Tannock, G. A., Paul, J. A. and Barry, R. D., Relative immunogenicity of the cold-adapted influenza virus A/Ann Arbor/6/60 (A/AA/6/60-ca), recombinants of A/AA/6/60-ca, and parental strains with similar surface antigens. Infect. Immun. 1984. 43: 457-462.
27. Harling-McNabb, L., Deliyannis, G., Jackson, D. C., Gerondakis, S., Grigoriadis, G. and Brown, L. E., Mice lacking the transcription factor subunit Rel can clear an influenza infection and have functional anti-viral cytotoxic T cells but do not develop an optimal antibody response. Int. Immunol. 1999. 11: 1431-1439.
28. + T cells in primary and secondary influenza pneumonia. Immunity 1998. 8: 683-691.